CLINICAL
SCIENCE FOCUS SESSION
Monitoring Anti-Cancer Therapy Response in the Clinic
Dachgarten 13:30 - 15:30 Chairs: N.R.
Jagannathan and Hendrik Von Tengg-Kobligk
Time |
Prog # |
|
13:30 | 555. |
Bayesian Mixed-Effect Model for Breast Cancer Treatment Studies Volker J. Schmid1, Brandon Whitcher2, N.Jane Taylor3, Anwar R. Padhani3, Guang-Zhong Yang1 1Imperial College, London, UK; 2GlaxoSmithKline, London, UK; 3Mount Vernon Hospital, Northwood, UK
|
13:40 | 556. |
Hyun-Man Baik1, Jeon-Hor Chen1, 2, Hon J. Yu1, Rita S. Mehta1, Orhan Nalcioglu1, Min-Ying Su1 1University of California-Irvine, Irvine, California, USA; 2China Medical University Hospital, Taichung 404, Taiwan
|
13:50 | 557. |
2D MRSI in Locally Advanced Breast Cancer: Assessment of Tumor Response in Patients Undergoing K A. Danishad1, V Seenu1, N R. Jagannathan1 1All India
Institute of Medical Sciences, New Delhi, Delhi, India |
14:00 | 558. |
Ke Nie1, Jeon-Hor Chen1, 2, Hon J. Yu1, Yong Chu1, Rita S. Mehta1, Orhan Nalcioglu1, Min-Ying Su1 1Tu & Yuen
Center for Functional Onco-Imaging, University of California, Irvine,
California, USA; 2Department of Radiology, China Medical University
Hospital, Taichung 404, Taiwan |
14:10 | 559. |
Does Diffusion Weighted Imaging Have a Role in Predicting Response to Neoadjuvant Chemotherapy? Martin D. Pickles1, Peter Gibbs1, Martin Lowry1, Lindsay W. Turnbull1 1University of Hull, Hull, East Yorkshire, UK |
14:20 | 560. |
Diffusion-Weighted MR Imaging of Colorectal Liver Metastases: Repeatability and Reproducibility of Apparent Diffusion Coefficients and Implications for Therapeutic Monitoring Keiko Miyazaki1, Erica Scurr2, David Collins1, Nandita deSouza1, Martin O. Leach1, Dow-Mu Koh1, 2 1Institute
of Cancer Research, Sutton, Surrey, UK; 2Royal Marsden Hospital,
Sutton, Surrey, UK |
14:30 | 561. |
DCE-MRI Parameters Are Predictive of Tumour Regression in Cervix Cancer Mark A. Zahra1, Evis Sala1, Andrew N. Priest1, Martin J. Graves1, Andrew B. Gill2, Sandeep S. Gupta3, Li Tee Tan2, Mark Arends1, Robin AF Crawford2, James D. Brenton1, David J. Lomas1 1University
of Cambridge, Cambridge, UK; 2Addenbrooke's Hospital, Cambridge, UK;
3National Naval Medical Center, Bethesda, Maryland, USA |
14:40 | 562. |
Dynamic Contrast Enhanced MRI of Solid Tumors Treated with NGR-TNF, a Novel Vascular Targeting Agent Hanneke W.M. van Laarhoven1, Jacques A. van Asten1, Carla M.L. van Herpen1, Salvatore Toma2, Claudio Bordignon2, Cornelis J.A. Punt1, Arend Heerschap1 1Radboud
University Nijmegen Medical Centre, Nijmegen, Netherlands; 2Molmed,
Italy |
14:50 | 563. |
Hon Yu1, Jeon-Hor Chen1, 2, Ke Nie1, Rita Mehta1, Orhan Nalcioglu1, Min-Ying Su1 1University of California, Irvine, California, USA; 2China Medical University Hospital, Taichung, Taiwan
|
15:00 | 564. |
Stefan Zwick1, 2, Eva Christina Woenne2, Ralph Strecker1, Michael Bock2, Arne Hengerer1, Matthias Taupitz3, Joerg Schnorr, 34, Bernd Misselwitz5, Wolfhard Semmler2, Fabian Kiessling2 1Siemens Medical Solutions, Erlangen, Germany; 2German Cancer Research Center, Heidelberg, Germany; 3Charité, Berlin, Germany; 4Ferropharm, Teltow, Germany; 5Schering, Berlin, Germany
|
15:10 | 565. |
Henry Mandeville1, N. Jane Taylor1, Quan Sing Ng1, Peter J. Hoskin1, Jessica Milner1, J. James Stirling1, James A. d'Arcy2, David J. Collins2, Michele I. Saunders1, Anwar R. Padhani1 1Mount
Vernon Hospital, Northwood, Middlesex, UK; 2Royal Marsden NHS
Foundation Trust, Sutton, Surrey, UK |
15:20 | 566. |
Jiachao Liang1, Johannnes Heverhagen2, Steffen Sammet1, Guang Jia1, Xiangyu Yang1, Regina Koch1, Manisha Shah1, Michael V. Knopp1 1The Ohio State University, Columbus, Ohio, USA; 2Philipps University, Marburg, Germany |